ESTUTC-5 New YorkLog in Sign up

ACR
ACRES Commercial Realty Corp.
stockNYSE

Market OpenNov 13, 2026 11:51:23 AM EST

9.40USD-3.093%(-0.30)17,312

ACR News

Day breaks

08:37 AM ESTACR Poker's $20M OSS Leads Sunday Action Alongside Quattro Day 2 and WSOP Paradise Packages ·

PR Newswire

07:00 PM ESTInnovent Showcases Preclinical Data of its First-in-Class IL-6 x TL1A Bispecific Antibody at ACR Convergence 2026 ·

PR Newswire

08:47 AM ESTACR Poker's $20 Million OSS Comes with Over $77,000 in Leaderboard Prizes ·

PR Newswire

10:11 PM ESTAntengene Presents Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026 ·

PR Newswire+2 sources

04:01 PM ESTPLX: Elfabrio Estimates Up, Again ·

Zacks Small Cap Research

08:48 AM ESTACR Poker's $500K Turbo Tuesday Mystery PKO Returns as the $20M OSS Hits Its Stride ·

PR Newswire

07:00 AM ESTNkarta Presents Initial Safety Data for NKX019 in 40 Patients Across Five Autoimmune Diseases at ACR Convergence 2026 ·

GlobeNewswire Inc.

12:30 PM ESTNovartis ianalumab two-year data at ACR show further improvements in Sjögren’s disease activity ·

GlobeNewswire Inc.

08:52 AM ESTACR Poker Crowns First Quattro Champions as $20 Million OSS Begins ·

PR Newswire

08:02 AM ESTTikva Allocell to Present Data at ACR Convergence 2026 Supporting a Potential Lymphodepletion-Free CAR T-Cell Approach for Systemic Lupus Erythematosus (SLE) ·

PR Newswire

03:00 PM ESTAllogene Therapeutics, Inc. ALLO-329: Autoimmune Disease Program Update from ACR Convergence ... ·

GuruFocus

11:00 AM ESTTwo HSS Rheumatologists Receive Prestigious National Career Honors at Annual American College of Rheumatology Meeting ·

Business Wire

10:30 AM ESTSetPoint Medical Presents 24-Month Data Demonstrating Sustained Clinical Benefit and Favorable Long-Term Safety of the SetPoint® System for Rheumatoid Arthritis ·

PR Newswire

10:12 AM ESTOrthoTrophix Presents Data on TPX-100, Meniscal Pathology and Structural Progression in Knee Osteoarthritis ·

PR Newswire

08:58 AM ESTLifordi Immunotherapeutics Presents Phase 1 Clinical Data for LFD-200, a Subcutaneous Glucocorticoid Antibody Drug Conjugate for Treatment of Autoimmune Disorders ·

Newsfile

08:00 AM ESTAisa Pharma to Present New Data from the Phase 2 RECONNOITER-1 Trial in Systemic Sclerosis-Associated Raynaud's Phenomenon at ACR Convergence 2026 ·

PR Newswire

08:00 AM ESTAllogene Therapeutics Reports First Clinical Data from Phase 1 RESOLUTION Study of ALLO-329 in Autoimmune Disease ·

GlobeNewswire Inc.

07:00 AM ESTHotSpot Therapeutics Presents Preclinical Data on Oral Small Molecule IRF5 Inhibitor HST‑2011 at ACR Convergence 2026 ·

PR Newswire